Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial nitric oxide synthase and endothelial dysfunction.

Paul L Huang1

  • 1Cardiovascular Research Center and Cardiovascular Division, Massachusetts General Hospital, 149 Thirteenth Street, Charlestown, MA 02129, USA. huangp@helix.mgh.harvard.edu

Current Hypertension Reports
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polygenic prediction of body mass index and obesity through the life course and across ancestries.

Nature medicine·2025
Same author

Near-Infrared II Photobiomodulation Preconditioning Ameliorates Stroke Injury via Phosphorylation of eNOS.

Stroke·2024
Same author

Correction: Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study.

Diabetology & metabolic syndrome·2024
Same author

The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.

PloS one·2023
Same author

Involvement of Endothelial Nitric Oxide Synthase in Cerebral Microcirculation and Oxygenation in Traumatic Brain Injury.

Advances in experimental medicine and biology·2022
Same author

Photobiomodulation and nitric oxide signaling.

Nitric oxide : biology and chemistry·2022
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Nitric oxide (NO) is vital for blood vessel health. Endothelial dysfunction, marked by reduced NO, is linked to diseases like hypertension and diabetes, potentially due to issues with eNOS phosphorylation.

Area of Science:

  • Vascular biology and endothelial function.

Background:

  • Nitric oxide (NO) plays a critical role in regulating vascular tone, blood flow, and cellular interactions within blood vessels.
  • Endothelial dysfunction, characterized by diminished bioavailable NO, is a hallmark of conditions including hypertension, diabetes, aging, and atherosclerosis.
  • Reduced nitric oxide bioavailability is a common pathway in various endothelial dysfunction states.

Purpose of the Study:

  • To review the physiological functions of nitric oxide (NO).
  • To elucidate the mechanisms underlying endothelial dysfunction.
  • To propose a unifying hypothesis for the common pathway in endothelial dysfunction.

Main Methods:

  • Review of existing literature on nitric oxide physiology and endothelial dysfunction.
  • Analysis of factors regulating endothelial nitric oxide synthase (eNOS) activity.

Related Experiment Videos

  • Examination of proposed mechanisms including fatty acid modifications, protein interactions, and phosphorylation.
  • Main Results:

    • Nitric oxide (NO) regulates key vascular functions.
    • Endothelial dysfunction is associated with decreased NO bioavailability.
    • Multiple factors influence endothelial nitric oxide synthase (eNOS) activity, including phosphorylation.

    Conclusions:

    • Endothelial dysfunction is a significant contributor to vascular diseases.
    • Abnormalities in endothelial nitric oxide synthase (eNOS) phosphorylation, particularly at Ser 1179, may represent a final common pathway for diverse causes of endothelial dysfunction.